Feasibility Of Outpatient Car-T Therapy For Lbcl

Feasibility of outpatient CAR-T therapy for LBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Feasibility of outpatient practice for CAR-T therapy in patients with lymphoma and multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Feasibility and safety of outpatient practice for recently approved CAR-T therapies

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-Cell Therapy as an Outpatient Treatment Option

Evaluating the Feasibility of Liso-cel Administration in the Outpatient Setting

Targeted Oncology

CAR T-Cell Program Feasibility in the Community Setting

CAR T Post-Infusion Care and Transitioning to Outpatient

Multiple Myeloma Patient Leads the Way as First CAR T-Cell Therapy Outpatient

Dana-Farber Cancer Institute

Outpatient management of CAR-T therapy in multiple myeloma and lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Preparing Cancer Centers for Outpatient CAR T-cell Administration

Targeted Oncology

Administering Outpatient CAR T-cell Therapy in Non-Hodgkin Lymphoma | Radhika Bansal, MD | EHA 2024

HealthTree Foundation for Blood Cancers

Outpatient Administration Potential of CAR T-Cell Therapy

Moving CAR-T therapy to the outpatient setting

VJHemOnc – Video Journal of Hematology & HemOnc

The impact of CAR-T therapy in the second-line setting in lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

What are the critical issues to address for outpatient administration of CAR T-cell therapy?

The future of CAR-T therapy in the management of DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-Cell Therapy Appears Promising in Relapsed/Refractory DLBCL

Targeted Oncology

Limitations of CAR T-cell therapy for DLBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Lymphodepletion for CAR T-Cell Therapies in DLBCL

When is a second CAR T-cell infusion feasible for patients who failed prior CAR T-cell therapy?